Immune System

© Getty Images

Angle launches PD-L1 test to support cancer therapy studies

By Isabel Cameron

Angle, a liquid biopsy company with circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, has launched its Portrait PD-L1 test for the evaluation of PD-L1 protein expression on CTCs.


Daiichi Sankyo inks Glycotope ADC deal

By Flora Southey

Daiichi Sankyo Company has signed an option agreement to develop Glycotope’s antibody drug conjugate (ADC) to target various cancers including ovarian, lung and breast tumours.


Fire ant venom to combat thick skin

By Flora Southey

Researchers say compounds from fire ant venom could be used to develop psoriasis treatments which limit skin-thickening side effects.


Merck boosts cancer pipeline in €464m deal

By Flora Southey

Merck & Co has announced it will acquire immunotherapy-focused Rigontec and lead candidate RGT100, designed to treat patients with solid tumours and lymphoma.